M. Alimandi, L. M. Wang, D. Bottaro, C. C. Lee, A. Kuo et al., Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors, The EMBO Journal, vol.16, issue.18, pp.5608-5625, 1997.
DOI : 10.1093/emboj/16.18.5608

C. Boucheix and E. Rubinstein, Tetraspanins, Cellular and Molecular Life Sciences, vol.58, issue.9, pp.1189-205, 2001.
DOI : 10.1007/PL00000933
URL : https://hal.archives-ouvertes.fr/inserm-00724944

J. O. Claudio, E. Masih-khan, H. Tang, J. Goncalves, M. Voralia et al., A molecular compendium of genes expressed in multiple myeloma, Blood, vol.100, issue.6, pp.2175-86, 2002.
DOI : 10.1182/blood-2002-01-0008

V. Costes, V. Magen, E. Legouffe, L. Durand, P. Baldet et al., The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens, Human Pathology, vol.30, issue.12, pp.1405-1416, 1999.
DOI : 10.1016/S0046-8177(99)90160-0

J. R. Couchman, Syndecans: proteoglycan regulators of cell-surface microdomains?, Nature Reviews Molecular Cell Biology, vol.4, issue.12, pp.926-963, 2003.
DOI : 10.1038/nrm1257

D. Vos, J. Couderc, G. Tarte, K. Jourdan, M. Requirand et al., Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays, Blood, vol.98, issue.3, pp.771-780, 2001.
DOI : 10.1182/blood.V98.3.771

Z. J. Gu, J. De-vos, C. Rebouissou, M. Jourdan, X. G. Zhang et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-97, 2000.
DOI : 10.1038/sj.leu.2401632

R. C. Harris, E. Chung, and R. J. Coffey, EGF receptor ligands, Experimental Cell Research, vol.284, issue.1, pp.2-13, 2003.
DOI : 10.1016/S0014-4827(02)00105-2

T. Holbro, G. Civenni, and N. E. Hynes, The ErbB receptors and their role in cancer progression, Experimental Cell Research, vol.284, issue.1, pp.99-110, 2003.
DOI : 10.1016/S0014-4827(02)00099-X

N. E. Hynes, K. Horsch, M. A. Olayioye, and A. Badache, The ErbB receptor tyrosine family as signal integrators, Endocrine Related Cancer, vol.8, issue.3, pp.151-160, 2001.
DOI : 10.1677/erc.0.0080151

S. Inui, S. Higashiyama, K. Hashimoto, M. Higashiyama, K. Yoshikawa et al., Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth, Journal of Cellular Physiology, vol.5, issue.3, pp.291-299, 1997.
DOI : 10.1002/(SICI)1097-4652(199706)171:3<291::AID-JCP7>3.0.CO;2-J

R. Iwamoto and E. Mekada, Heparin-binding EGF-like growth factor: a juxtacrine growth factor, Cytokine & Growth Factor Reviews, vol.11, issue.4, pp.335-344, 2000.
DOI : 10.1016/S1359-6101(00)00013-7

M. Jourdan, J. De-vos, N. Mechti, and B. Klein, Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1, Cell Death and Differentiation, vol.7, issue.12, pp.1244-1252, 2000.
DOI : 10.1038/sj.cdd.4400758
URL : https://hal.archives-ouvertes.fr/inserm-00130981

B. Klein, K. Tarte, M. Jourdan, K. Mathouk, J. Moreaux et al., Survival and Proliferation Factors of Normal and Malignant Plasma Cells, International Journal of Hematology, vol.276, issue.2, pp.106-119, 2003.
DOI : 10.1007/BF02983377
URL : https://hal.archives-ouvertes.fr/inserm-00130900

T. J. Lynch, D. W. Bell, R. Sordella, S. Gurubhagavatula, R. A. Okimoto et al., Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non???Small-Cell Lung Cancer to Gefitinib, New England Journal of Medicine, vol.350, issue.21, pp.2129-2168, 2004.
DOI : 10.1056/NEJMoa040938

K. Mahtouk, M. Jourdan, J. De-vos, C. Hertogh, G. Fiol et al., An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis, Blood, vol.103, issue.5, pp.1829-1866, 2004.
DOI : 10.1182/blood-2003-05-1510
URL : https://hal.archives-ouvertes.fr/inserm-00130207

C. Manegold, Gefitinib (Iressa, Zd 1839) for Non-Small Cell Lung Cancer (Nsclc): Recents Results and Further Strategies, Adv Exp Med Biol, vol.532, pp.247-52, 2003.
DOI : 10.1007/978-1-4615-0081-0_20

N. Nylander, L. T. Smith, R. A. Underwood, and M. Piepkorn, Topography of amphiregulin expression in cultured human keratinocytes: Colocalization with the epidermal growth factor receptor and CD44, In Vitro Cellular & Developmental Biology - Animal, vol.243, issue.2, pp.182-190, 1998.
DOI : 10.1007/s11626-998-0103-0

J. G. Paez, P. A. Janne, J. C. Lee, S. Tracy, H. Greulich et al., EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy, Science, vol.304, issue.5676, pp.1497-500, 2004.
DOI : 10.1126/science.1099314

A. C. Rapraeger, Syndecan-Regulated Receptor Signaling, The Journal of Cell Biology, vol.19, issue.5, pp.995-1003, 2000.
DOI : 10.1016/S0955-0674(98)80038-0
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174822

T. Sakuma, S. Higashiyama, S. Hosoe, S. Hayashi, and N. Taniguchi, CD9 Antigen Interacts with Heparin-Binding EGF-Like Growth Factor through Its Heparin-Binding Domain, Journal of Biochemistry, vol.122, issue.2, pp.474-80, 1997.
DOI : 10.1093/oxfordjournals.jbchem.a021776

D. Walters, J. French, B. Arendt, and D. Jelinek, Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-?? signaling complex, Oncogene, vol.22, issue.23, pp.3598-3607, 2003.
DOI : 10.1038/sj.onc.1206512

L. M. Wang, A. Kuo, M. Alimandi, M. C. Veri, C. C. Lee et al., ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4, Proceedings of the National Academy of Sciences, vol.91, issue.20, pp.6809-6823, 1998.
DOI : 10.1073/pnas.91.20.9387

Y. D. Wang, J. De-vos, M. Jourdan, G. Couderc, Z. Y. Lu et al., Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells, Oncogene, vol.21, issue.16, pp.2584-92, 2002.
DOI : 10.1038/sj.onc.1205355

F. Zhan, J. Hardin, B. Kordsmeier, K. Bumm, M. Zheng et al., Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells, Blood, vol.99, issue.5, pp.1745-57, 2002.
DOI : 10.1182/blood.V99.5.1745